Nearly two years after the first reported case of the coronavirus in the country, the federal government is preparing to release millions of vaccine doses to kids 6 months to 5-years-old if the FDA and CDC approve. This comes as new COVID-19 cases plunge nationwide, and a growing number of states ease restrictions.
By Matthew Perrone
Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness.
Pfizer says it is testing an omicron-specific vaccine booster. This comes as the FDA faces backlash over its decision to halt the use of two antibody treatments.
A new warning about fake COVID-19 rapid tests being sold online.
In the midst of the surge of COVID cases the FDA is now allowing Pfizer booster shots for children as young as 12 years old.
The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12. Boosters already are recommended for everyone 16 and older, and the FDA says they’re also warranted for 12- to 15-year-olds.
Ahead of the Christmas holiday, officials are scrambling to combat the fast spreading omicron variant. This comes as the FDA issues emergency use authorization for Pfizer’s COVID-19 treatment pill.
Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the FDA. It’s part of the company’s application to authorize the pill for emergency use.
The Food and Drug Administration has opened up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine. But there’s one more step: The Centers for Disease Control and Prevention must agree that even healthy young adults should get either a Pfizer or Moderna booster.
Moderna says the Food and Drug Administration needs more time to review its COVID-19 vaccine in teenagers. Moderna says the FDA wants to review the risk of heart inflammation in its vaccine in children and teens ages 12-17.